Bukowski Rm

1k citations
22 papers · 873 · h-index 12

Impact in

  • Immunology top 5%
    • Complement system in diseases
  • Hematology top 5%
    • Erythropoietin and Anemia Treatment
    • Platelet Disorders and Treatments

Papers in

    • Cancer Immunotherapy and Biomarkers 2
    • Colorectal Cancer Treatments and Studies 2
    • Neutropenia and Cancer Infections 1
    • Erythropoietin and Anemia Treatment 1

Bukowski Rm

22 papers receiving 747 citations

Peers

Bukowski Rm
Comparison fields: 5 of 49
  • Immunology 397
  • Hematology 198
  • Biochemistry 45
  • Oncology 80
  • Pulmonary and Respiratory Medicine 74
Replace Eugene M. Berkman with:
Eugene M. Berkman United States
Nirmala Bhoopalam United States
Paolo Alberto Paciucci United States
Margaret A. Reisberg United States
Gregory Clayton Connolly United States
A. Jake Demetris United States
Toshiki Yamada Japan
Marion S. Sternbach Canada
Manuela Krause Germany
Robert Delage Canada
Bukowski Rm relative to Eugene M. Berkman United States Eugene M. Berkman's profile →
Citations per field
00.5×2×3.2×
Eugene M. Berkman · 1×
Citations per year

Countries citing papers authored by Bukowski Rm

Since Specialization
Citations

This map shows the geographic impact of Bukowski Rm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bukowski Rm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bukowski Rm more than expected).

Fields of papers citing papers by Bukowski Rm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bukowski Rm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bukowski Rm. The network helps show where Bukowski Rm may publish in the future.

Co-authors

The 25 scholars most cited alongside Bukowski Rm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bukowski Rm Line = papers co-authored together Bukowski Rm links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1977213
2 1993172
3
Thrombotic thrombocytopenic purpura: a review.
1982125
4
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura.
1976114
5
Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.
200043
6
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.
198135
7
Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
197932
8
Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
198028
9
Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
198217
10
Treatment of severe aplastic anemia with antithymocyte globulin.
198213
11
Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma.
199013
12 199513
13 198311
14
Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
19839
15
Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
19838
16
Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
19906
17
Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.
19775
18
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
19875
19
Acute colonic pseudo-obstruction associated with interleukin-2 therapy.
19914
20
Biologic therapy in patients receiving salvage treatment.
19943

About Bukowski Rm

Bukowski Rm is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Immunology and Otorhinolaryngology, having authored 22 papers that have together received 873 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), Complement system in diseases (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Erythropoietin and Anemia Treatment (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Immunology (397 citations), Hematology (198 citations), Biochemistry (45 citations), Oncology (80 citations) and Pulmonary and Respiratory Medicine (74 citations). Bukowski Rm has collaborated with scholars based in United States. Frequent co-authors include Hewlett Js, Carl W. Groppe, Harris Jw, Weick Jk, Robert J. Jacobson, Stephen E. Jones, J. W. Kugler, David H. Henry, Richard T. Silver and Robert W. Carey. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, JNCI Journal of the National Cancer Institute, The Annals of Thoracic Surgery and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact